We have located links that may give you full text access.
Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer's disease with PET imaging agents 18 F-flutemetamol and 18 F-florbetaben.
BMC Neuroscience 2018 July 28
BACKGROUND: Although amyloid beta (Aβ) imaging is widely used for diagnosing and monitoring Alzheimer's disease in clinical fields, paralleling comparison between 18 F-flutemetamol and 18 F-florbetaben was rarely attempted in AD mouse model. We performed a comparison of Aβ PET images between 18 F-flutemetamol and 18 F-florbetaben in a recently developed APPswe mouse model, C57BL/6-Tg (NSE-hAPPsw) Korl.
RESULTS: After an injection (0.23 mCi) of 18 F-flutemetamol and 18 F-florbetaben at a time interval of 2-3 days, we compared group difference of SUVR and kinetic parameters between the AD (n = 7) and control (n = 7) mice, as well as between 18 F-flutemetamol and 18 F-florbetaben image. In addition, bio-distribution and histopathology were conducted. With visual image and VOI-based SUVR analysis, the AD group presented more prominent uptake than did the control group in both the 18 F-florbetaben and 18 F-flutemetamol images. With kinetic analysis, the 18 F-florbetaben images showed differences in K1 and k4 between the AD and control groups, although 18 F-flutemetamol images did not show significant difference. 18 F-florbetaben images showed more prominent cortical uptake and matched well to the thioflavin S staining images than did the 18 F-flutemetamol image. In contrast, 18 F-flutemetamol images presented higher K1, k4, K1/k2 values than those of 18 F-florbetaben images. Also, 18 F-flutemetamol images presented prominent uptake in the bowel and bladder, consistent with higher bio-distribution in kidney, lung, blood and heart.
CONCLUSIONS: Compared with 18 F-flutemetamol images, 18 F-florbetaben images showed prominent visual uptake intensity, SUVR, and higher correlations with the pathology. In contrast, 18 F-flutemetamol was more actively metabolized than was 18 F-florbetaben (Son et al. in J Nucl Med 58(Suppl 1):S278, 2017].
RESULTS: After an injection (0.23 mCi) of 18 F-flutemetamol and 18 F-florbetaben at a time interval of 2-3 days, we compared group difference of SUVR and kinetic parameters between the AD (n = 7) and control (n = 7) mice, as well as between 18 F-flutemetamol and 18 F-florbetaben image. In addition, bio-distribution and histopathology were conducted. With visual image and VOI-based SUVR analysis, the AD group presented more prominent uptake than did the control group in both the 18 F-florbetaben and 18 F-flutemetamol images. With kinetic analysis, the 18 F-florbetaben images showed differences in K1 and k4 between the AD and control groups, although 18 F-flutemetamol images did not show significant difference. 18 F-florbetaben images showed more prominent cortical uptake and matched well to the thioflavin S staining images than did the 18 F-flutemetamol image. In contrast, 18 F-flutemetamol images presented higher K1, k4, K1/k2 values than those of 18 F-florbetaben images. Also, 18 F-flutemetamol images presented prominent uptake in the bowel and bladder, consistent with higher bio-distribution in kidney, lung, blood and heart.
CONCLUSIONS: Compared with 18 F-flutemetamol images, 18 F-florbetaben images showed prominent visual uptake intensity, SUVR, and higher correlations with the pathology. In contrast, 18 F-flutemetamol was more actively metabolized than was 18 F-florbetaben (Son et al. in J Nucl Med 58(Suppl 1):S278, 2017].
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app